Palforzia (defatted powder of Arachis hypogaea L., semen (peanuts))
Additional monitoring
- Region
- 🇪🇺 EU
- Active substance
- defatted powder of Arachis hypogaea L., semen (peanuts)
- Company
- Stallergenes
- Status
- Authorised
- Therapeutic area
- Peanut Hypersensitivity
- CHMP opinion
- Thu 15 Oct 2020
- EU approval
- Thu 17 Dec 2020
- Designations
- Additional monitoring
- Application
- EMEA/H/C/004917
- ATC
- V01
- Official record
- www.ema.europa.eu
Indication
Palforzia is indicated for the treatment of patients aged 1 to 17 years with a confirmed diagnosis of peanut allergy. Palforzia may be continued in patients 18 years of age and older. Palforzia should be used in conjunction with a peanut-avoidant diet.
Regulatory milestones
No milestones recorded in the last year.
Follow Palforzia
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.